RHT.AX - Resonance Health Limited

ASX - ASX Delayed Price. Currency in AUD

Resonance Health Limited

141 Burswood Road
Ground Floor Suite 2
Burswood, WA 6100
61 8 9286 5300

IndustryMedical Appliances & Equipment
Full Time Employees

Key Executives

Dr. Timothy Guy St. Pierre B.Sc(Hons), Ph.D.Chief Scientific Officer205.24kN/AN/A
Dr. Jason Loveridge B.Sc, Ph.D., FRSMCorp. Advisor40kN/AN/A
Ms. Alison LawsChief Exec. OfficerN/AN/AN/A
Mr. Agha Shahzad Pervez B.Sc.CFO & Company Sec.N/AN/AN/A
Ms. Melanie BaxterMarketing DirectorN/AN/AN/A
Amounts are as of December 31, 2017 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.


Resonance Health Limited, a healthcare company, engages in the development and commercialization of technologies and services for the quantitative analysis of radiological images in a regulated and quality controlled environment in Asia Pacific, North America, Europe, the Middle East, and Africa. Its flagship product is FerriScan, a non-invasive liver diagnostic technology used for the measurement of liver iron concentration. The company also provides Cardiac T2, a dual analysis service with FerriScan to provide information regarding body iron stores; HepaFat-Scan, a magnetic resonance imaging (MRI) based tool for the measurement of volumetric liver fat fraction; and Bone Marrow R2-MRI for the assessment of iron levels in the bone marrow. It also provides imaging core laboratory and support services for clinical trials, including clinical measurement, as well as project and data management services, such as reporting, administration, and support. The company serves clinicians for the diagnosis and management of human diseases; and pharmaceutical companies for their clinical trials. Resonance Health Limited has a strategic partnership with Perth Radiological Clinic to assess the viability of the development and commercialization of various diagnostic tools. The company is headquartered in Burswood, Australia.

Corporate Governance

Resonance Health Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.